ask="11.95"
ask_size="300"
average_daily_volume="19269"
bid="5.05"
bid_size="200"
book_value="0.34"
change="+0.15"
change_from_200_day_moving_average="0.11"
change_from_50_day_moving_average="0.09"
change_from_52_week_high="-2.45"
change_From_52_week_low="2.40"
change_in_percent="+2.80%"
close="5.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.42"
ebitda="-10.75M"
eps_estimate_current_year="-0.49"
eps_estimate_next_quarter="-0.11"
eps_estimate_next_year="-0.52"
ex_dividend_date="N/A"
float_shares="3528000"
high="5.50"
high_52_weeks="7.95"
last_trade_date="3/17/2017"
last_trade_price="5.50"
last_trade_size="700"
last_trade_time="4:03pm"
low="5.39"
low_52_weeks="3.10"
market_capitalization="161.49M"
moving_average_200_day="5.39"
moving_average_50_day="5.41"
name="OncoCyte Corporation"
notes="N/A"
one_year_target_price="8.88"
open="5.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+1.99%"
percent_change_from_50_day_moving_average="+1.65%"
percent_change_from_52_week_high="-30.82%"
percent_change_from_52_week_low="+77.42%"
previous_close="5.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="15.60"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="29361000"
short_ratio="2.98"
stock_exchange="ASE"
symbol="OCX"
volume="11501"
weeks_range_52="3.10 - 7.95"
